Core B-Clinical Data Collection and Management Core

核心 B-临床数据收集和管理核心

基本信息

  • 批准号:
    10555683
  • 负责人:
  • 金额:
    $ 638.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

ABSTRACT Clinical Data Collection and Management Core Knee osteoarthritis (OA) is among the world's most disabling diseases, and it accounts for a substantial percentage of the increase in disability life years. The Multicenter Osteoarthritis (MOST) Study has made major contributions to our understanding of the course of OA and identification of risk factors for its incidence and progression. Beginning in 2003, the MOST initially enrolled 3026 participants with or at high risk of knee OA. In the most recent phase (MOST3), an additional 1525 participants who were slightly younger and unlikely to have advanced disease were enrolled. Despite the insights provided by the previous phases of MOST, there are still no treatments available that slow progression of OA. The next phase (MOST4) focuses on three major scientific projects that address key gaps in knowledge in OA. These projects include: Impaired Exercise-Induced Hypoalgesia (Project 1); Synovial Fluid Proteomics (Project 2); and Intra-articular Mineralization (Project 3). These projects will be supported by four Cores – the Administrative Core, the Imaging Core, the Analysis Core, and the Clinical Data Collection and Management Core (CDCMC). The overarching goal of the CDCMC is to ensure the success of the MOST projects by providing an outstanding infrastructure for visit enrollment, study procedures and data collection, and longitudinal ascertainment of critical outcomes. This core includes the Coordinating Center (led by Peggy Cawthon at UCSF) and the MOST clinical centers: University of Iowa (UI clinic center lead: James Torner) and University of Alabama, Birmingham (UAB clinic center lead: Cora E. Lewis). Specially, the aims of the CDCMC are to: 1) To enroll 2143 existing MOST participants, and 150 newly recruited participants from underrepresented racial and ethnic minority groups, for the MOST4 V1 examination (2293 total), and follow those participants for the MOST4 V2 examination, 2) Ensure the collection of high-quality research data and specimens, 3) To maintain a high rate of retention of study participants and complete ascertainment of study outcomes, 4) To ensure the safety of participants and to meet regulatory standards, 5) Collect, clean, document and integrate MOST data across all projects and cores.
临床数据收集和管理核心 膝关节骨关节炎(OA)是世界上最致残的疾病之一,它占了相当大的比例, 残疾寿命年增长的百分比。多中心骨关节炎(MOST)研究已经取得了重大进展, 有助于我们理解OA的病程和识别其发病的风险因素, 进展从2003年开始,MOST最初招募了3026名患有膝关节OA或膝关节OA高风险的参与者。在 最近一个阶段(MOST 3),另外1525名参与者,他们稍微年轻,不太可能有 入组了晚期疾病。尽管社会变革管理计划的前几个阶段提供了深刻的见解, 没有可用的治疗方法来减缓OA的进展。下一阶段(MOST 4)的重点是三个主要的科学 解决开放式获取知识方面的关键差距的项目。这些项目包括: 痛觉减退(项目1);滑液蛋白质组学(项目2);和关节内矿化(项目3)。 这些项目将得到四个核心的支持-行政核心,成像核心,分析核心, 临床数据收集和管理核心(CDCMC)。CDCMC的总体目标是 通过为访问、注册、学习和培训提供出色的基础设施,确保MOST项目的成功 程序和数据收集,以及关键结果的纵向确定。该核心包括 协调中心(由UCSF的Peggy Cawthon领导)和MOST临床中心:爱荷华州大学(UI 临床中心负责人:James Torner)和伯明翰亚拉巴马大学(UAB临床中心负责人:Cora E. 刘易斯)。具体而言,CDCMC的目标是:1)招募2143名现有MOST参与者,150名新参与者 从代表性不足的种族和少数民族群体中招募参与者,参加MOST 4 V1考试 (2293 2)确保收集高质量的 研究数据和标本,3)保持研究参与者的高保留率和完整性 确定研究结果,4)确保参与者的安全并符合监管标准,5) 收集、清理、记录和整合所有项目和核心的MOST数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peggy Mannen Cawthon其他文献

Peggy Mannen Cawthon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peggy Mannen Cawthon', 18)}}的其他基金

Novel Computed Tomography (CT) Imaging Biomarkers in Older Adults for Predicting Adverse Geriatric Health Outcomes
用于预测老年人不良健康结果的新型计算机断层扫描 (CT) 成像生物标志物
  • 批准号:
    10303313
  • 财政年份:
    2021
  • 资助金额:
    $ 638.93万
  • 项目类别:
Novel Computed Tomography (CT) Imaging Biomarkers in Older Adults for Predicting Adverse Geriatric Health Outcomes
用于预测老年人不良健康结果的新型计算机断层扫描 (CT) 成像生物标志物
  • 批准号:
    10458743
  • 财政年份:
    2021
  • 资助金额:
    $ 638.93万
  • 项目类别:
AMPLIFIed muscle mass in older cancer survivors enrolled in a diet-exercise program
参加饮食锻炼计划的老年癌症幸存者的肌肉质量增加
  • 批准号:
    10531199
  • 财政年份:
    2019
  • 资助金额:
    $ 638.93万
  • 项目类别:
AMPLIFIed muscle mass in older cancer survivors enrolled in a diet-exercise program
参加饮食锻炼计划的老年癌症幸存者的肌肉质量增加
  • 批准号:
    9888993
  • 财政年份:
    2019
  • 资助金额:
    $ 638.93万
  • 项目类别:
AMPLIFIed muscle mass in older cancer survivors enrolled in a diet-exercise program
参加饮食锻炼计划的老年癌症幸存者的肌肉质量增加
  • 批准号:
    10311067
  • 财政年份:
    2019
  • 资助金额:
    $ 638.93万
  • 项目类别:
Translational Epidemiology - Training for Research on Aging and Chronic disease
转化流行病学 - 老龄化和慢性病研究培训
  • 批准号:
    10641744
  • 财政年份:
    2016
  • 资助金额:
    $ 638.93万
  • 项目类别:
Translational Epidemiology - Training for Research on Aging and Chronic disease
转化流行病学 - 老龄化和慢性病研究培训
  • 批准号:
    10411498
  • 财政年份:
    2016
  • 资助金额:
    $ 638.93万
  • 项目类别:
Determination of Skeletal Muscle Mass by Creatine Dilution
肌酸稀释法测定骨骼肌质量
  • 批准号:
    8653228
  • 财政年份:
    2013
  • 资助金额:
    $ 638.93万
  • 项目类别:
Determination of Skeletal Muscle Mass by Creatine Dilution
肌酸稀释法测定骨骼肌质量
  • 批准号:
    8919080
  • 财政年份:
    2013
  • 资助金额:
    $ 638.93万
  • 项目类别:
Determination of Skeletal Muscle Mass by Creatine Dilution
肌酸稀释法测定骨骼肌质量
  • 批准号:
    8735074
  • 财政年份:
    2013
  • 资助金额:
    $ 638.93万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 638.93万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了